
GLOW Blend 70mg (50mg/10mg/10mg)
- Tissue repair and regeneration
- Collagen synthesis and skin remodelling

£9.95 per mg · 20mg total
Choose your pack
Certificate of analysis
Independent test results for this batch, tested by Janoshik Analytical.
Batch MRL-26Q3-A11
MS
Mass-spec confirmed identity
LAL
Endotoxin tested to established limits
UK
Synthesised and tested in Britain
Supplied as a liquid peptide solution in a 3ml research cartridge. Contains Semax (20mg). A synthetic ACTH(4-10) analogue developed in Russia, studied in BDNF/NGF expression, neuroprotection, and ischaemic recovery models.
Format
Liquid peptide solution, 20mg
Molecular formula
C₃₇H₅₁N₉O₁₀S
Molecular weight
813.93 g/mol
Abbreviation
SMX
A vial arrives as powder that must be prepared, measured and transferred by hand. The Mercia Pen arrives pre-filled.
Store
Store immediately at 2–8°C upon delivery. Do not freeze.
Shipping
Shipped in validated temperature-controlled packaging to maintain product stability during transit.
Avoid Freezing
Do not freeze, as freezing may compromise product quality.
Temperature Tolerance
Stabilised below 25°C for delivery. Should not be exposed to higher temperatures.
3rd Party Tested
Independently tested for heavy metals, residual solvents and endotoxins to established limits.
Full Traceability
Batch-level traceability from production to delivery.
Certificate of Analysis
Lot-matched 3rd party CoA with every batch. Available on our website.
Shelf Life
12 months from manufacture when stored at 2–8°C.
Semax is a synthetic heptapeptide analogue of the ACTH(4-10) fragment of adrenocorticotropic hormone, sometimes written Semax peptide. Developed at the Institute of Molecular Genetics in Moscow and supplied here as a UK-manufactured liquid peptide solution for researchers looking to buy Semax in the UK, it has been the subject of extensive neurological research, particularly in the areas of neuroprotection and cognitive function.
One of the most studied aspects of Semax is its influence on neurotrophic factor expression. Research has examined its effects on brain-derived neurotrophic factor (BDNF) upregulation in hippocampal and cortical tissue, nerve growth factor (NGF) expression in preclinical models, and the downstream effects of neurotrophic signalling on neuronal survival and plasticity.
Semax has attracted interest in neuroprotective research contexts. Studies have investigated its protective effects in models of oxidative stress-induced neural damage, interactions with anti-apoptotic signalling cascades in neural tissue, and its effects on microglial activation and neuroinflammatory mediators.
A significant body of preclinical research has examined Semax in cerebral ischaemia models. Research has explored its effects on infarct volume following experimental ischaemic events, neurovascular unit preservation in stroke models, and recovery of neurological function in preclinical settings.
Semax has also been studied in relation to monoamine neurotransmitter systems, including dopamine receptor sensitivity modulation and serotonin turnover in brain regions associated with mood and cognition.
For laboratory research use only. Not intended for human or animal consumption.
Yes. Every order ships with a third-party CoA matched to the lot number printed on your cartridge. A sample CoA is available on the site.
Each batch is HPLC-tested for purity and mass-spec confirmed for identity, then tested for heavy metals, residual solvents and endotoxins.
No. The cartridge is supplied as a ready-to-use liquid solution in 3ml bacteriostatic water.
Validated temperature-controlled packaging, UK next-day dispatch. Store at 2–8°C on arrival, do not freeze, 12-month shelf life.
Qualified personnel for in vitro laboratory research and analytical work only. Not for human or animal consumption.




